| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity | 1.36e-04 | 11 | 32 | 2 | GO:0052629 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate phosphatase activity | 2.24e-04 | 14 | 32 | 2 | GO:0004438 | |
| GeneOntologyMolecularFunction | phosphatidylinositol monophosphate phosphatase activity | 2.58e-04 | 15 | 32 | 2 | GO:0052744 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate phosphatase activity | 2.94e-04 | 16 | 32 | 2 | GO:0106018 | |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate phosphatase activity | 8.52e-04 | 27 | 32 | 2 | GO:0034593 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate phosphatase activity | 1.05e-03 | 30 | 32 | 2 | GO:0052866 | |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol dephosphorylation | 3.27e-05 | 6 | 31 | 2 | GO:0060304 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.91e-04 | 656 | 30 | 6 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.96e-04 | 658 | 30 | 6 | GO:0030312 | |
| Domain | PPASE_MYOTUBULARIN | 2.24e-04 | 14 | 30 | 2 | PS51339 | |
| Domain | Myotubularin_fam | 2.24e-04 | 14 | 30 | 2 | IPR030564 | |
| Domain | Myotub-related | 2.24e-04 | 14 | 30 | 2 | PF06602 | |
| Domain | Myotubularin-like_Pase_dom | 2.24e-04 | 14 | 30 | 2 | IPR010569 | |
| Domain | FYVE | 9.86e-04 | 29 | 30 | 2 | PF01363 | |
| Domain | FYVE | 9.86e-04 | 29 | 30 | 2 | SM00064 | |
| Domain | Znf_FYVE-rel | 1.36e-03 | 34 | 30 | 2 | IPR017455 | |
| Domain | Znf_FYVE | 1.69e-03 | 38 | 30 | 2 | IPR000306 | |
| Domain | ZF_FYVE | 1.87e-03 | 40 | 30 | 2 | PS50178 | |
| Domain | Quinoprotein_ADH-like_supfam | 3.27e-03 | 53 | 30 | 2 | IPR011047 | |
| Domain | - | 3.37e-03 | 391 | 30 | 4 | 2.30.29.30 | |
| Domain | PH_dom-like | 4.57e-03 | 426 | 30 | 4 | IPR011993 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 27417586 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 23036009 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 19198611 | ||
| Pubmed | 5' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. | 2.46e-06 | 3 | 32 | 2 | 7679504 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 11302699 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 30944173 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 21900290 | ||
| Pubmed | The PtdIns3-phosphatase MTMR3 interacts with mTORC1 and suppresses its activity. | 8.19e-06 | 5 | 32 | 2 | 26787466 | |
| Pubmed | Genetic and clinical correlates of early-outgrowth colony-forming units. | 8.19e-06 | 5 | 32 | 2 | 21493818 | |
| Pubmed | Characterization of the myotubularin dual specificity phosphatase gene family from yeast to human. | 3.67e-05 | 10 | 32 | 2 | 9736772 | |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 4.14e-05 | 211 | 32 | 4 | 24097068 | |
| Pubmed | 5.38e-05 | 12 | 32 | 2 | 16787938 | ||
| Pubmed | Common variants at five new loci associated with early-onset inflammatory bowel disease. | 5.38e-05 | 12 | 32 | 2 | 19915574 | |
| Pubmed | 1.39e-04 | 19 | 32 | 2 | 18711365 | ||
| Pubmed | 1.54e-04 | 20 | 32 | 2 | 21689717 | ||
| Pubmed | 3.75e-04 | 31 | 32 | 2 | 27321927 | ||
| Pubmed | 5.67e-04 | 418 | 32 | 4 | 34709266 | ||
| Pubmed | 9.01e-04 | 48 | 32 | 2 | 24262325 | ||
| Cytoband | 7q11.23 | 4.34e-05 | 97 | 32 | 3 | 7q11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | 8.89e-04 | 271 | 32 | 3 | chr7q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q33 | 3.09e-03 | 118 | 32 | 2 | chr5q33 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q31 | 4.13e-03 | 137 | 32 | 2 | chr9q31 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 1.61e-04 | 15 | 23 | 2 | 903 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 7.04e-04 | 31 | 23 | 2 | 81 | |
| GeneFamily | Phosphoinositide phosphatases | 7.50e-04 | 32 | 23 | 2 | 1079 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_P7 | 4.54e-06 | 91 | 32 | 4 | M1736 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_P7 | 4.95e-06 | 93 | 32 | 4 | MM1218 | |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL | 4.63e-05 | 164 | 32 | 4 | M41676 | |
| Coexpression | CAMP_UP.V1_DN | 9.81e-05 | 199 | 32 | 4 | M2719 | |
| Coexpression | GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP | 1.00e-04 | 200 | 32 | 4 | M5559 | |
| Coexpression | GSE14350_TREG_VS_TEFF_DN | 1.00e-04 | 200 | 32 | 4 | M3418 | |
| Coexpression | LIAN_LIPA_TARGETS_6M | 1.37e-04 | 82 | 32 | 3 | M4345 | |
| Coexpression | NABA_MATRISOME | 1.76e-04 | 1008 | 32 | 7 | MM17056 | |
| Coexpression | NABA_MATRISOME | 1.97e-04 | 1026 | 32 | 7 | M5889 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.02e-07 | 200 | 32 | 5 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 5.52e-06 | 163 | 32 | 4 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.22e-06 | 168 | 32 | 4 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.22e-06 | 168 | 32 | 4 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.36e-06 | 169 | 32 | 4 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.82e-06 | 172 | 32 | 4 | bc3ed05fdd94d5e1f19285aea867b1453292baec | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue | 7.14e-06 | 174 | 32 | 4 | 0746344d62aa7ab77c378e9d5a9f9238e741a76b | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.64e-06 | 177 | 32 | 4 | 4672cc75225a4a23b298afa8ce439628262519db | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.99e-06 | 179 | 32 | 4 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Macrophage|lymph-node_spleen / Manually curated celltypes from each tissue | 8.71e-06 | 183 | 32 | 4 | 0bcbd60e10b9d6898915dab1987fd46dc7238b19 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.89e-06 | 189 | 32 | 4 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 9.89e-06 | 189 | 32 | 4 | aac79c41ce7acba722c45c016b2c6997fb772a96 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-05 | 196 | 32 | 4 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-05 | 197 | 32 | 4 | bb35a2b7320fda92e9cd42f536b7bd54e3a73a32 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 197 | 32 | 4 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.19e-05 | 198 | 32 | 4 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.21e-05 | 199 | 32 | 4 | 7f4840ae6a888380feca722543e5e52783f3e35d | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.21e-05 | 199 | 32 | 4 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.21e-05 | 199 | 32 | 4 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.21e-05 | 199 | 32 | 4 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.21e-05 | 199 | 32 | 4 | 9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.21e-05 | 199 | 32 | 4 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-05 | 200 | 32 | 4 | 750ff51c9de08aecec230f4a402e0bf5a789f24c | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.24e-05 | 200 | 32 | 4 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.07e-05 | 112 | 32 | 3 | 9801227fe5a6f5ae1b6c5a9e7fa7f35c4c52efe1 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.46e-04 | 143 | 32 | 3 | cc396b81a5e47d78c2d1cb49d682391376b63476 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-04 | 144 | 32 | 3 | 013223bb2f31eb5bebdbd0908b797d28b96c6f7b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.68e-04 | 150 | 32 | 3 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.74e-04 | 152 | 32 | 3 | 0652ee3443e6fbb679d2c4f326239ae7c803f924 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.92e-04 | 157 | 32 | 3 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.96e-04 | 158 | 32 | 3 | 7f5426585d0d299d2b48e5fcb349950feffdef33 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 158 | 32 | 3 | 66c011e9de002224f70725dfe8e7871c8d304492 | |
| ToppCell | Club_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.07e-04 | 161 | 32 | 3 | bd08a23b415617f6e8748ed2668d578a860ecf91 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.07e-04 | 161 | 32 | 3 | 98be0cf8228496b31f7f3e0efd8787e95eb626d1 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.07e-04 | 161 | 32 | 3 | 7af3b0d4fc7967f6b3e2d255d23fd8b1fd01a7af | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.30e-04 | 167 | 32 | 3 | 49b19159c62d33d65ed1e59a148c11ae902fd41c | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac-Intermediate_macrophages|bone_marrow / Manually curated celltypes from each tissue | 2.34e-04 | 168 | 32 | 3 | 8ade4d098aeecda2d80c1cad1cebe9a063eae948 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-04 | 171 | 32 | 3 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 173 | 32 | 3 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 2.55e-04 | 173 | 32 | 3 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 173 | 32 | 3 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 173 | 32 | 3 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.60e-04 | 174 | 32 | 3 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-04 | 175 | 32 | 3 | 91cb819a1786020713b7e64480de0545380daae9 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-progenitor-Germ|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-04 | 176 | 32 | 3 | eea554ea75580f8dd5fefb57e7f33441ab86b884 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-04 | 176 | 32 | 3 | d5cee483d2a60f82fdc67ad447b589d022fe8c97 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC2|lymph-node_spleen / Manually curated celltypes from each tissue | 2.69e-04 | 176 | 32 | 3 | 72a3bbab0540ae3e3c94b9573cdb9298a024dbc4 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.73e-04 | 177 | 32 | 3 | 709235694cc711b9b79690e23c94577b2ae06811 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.73e-04 | 177 | 32 | 3 | 2b675840b7d2bb536c2c600936733bd9e97e7120 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.73e-04 | 177 | 32 | 3 | 5e0fca9bd5e5ffe6d39f5bcd81f36512f3b0cb1b | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Zbtb32+_B_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.73e-04 | 177 | 32 | 3 | a58c93be9767e3fe8fbb6b0db1210d3a33aac662 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.73e-04 | 177 | 32 | 3 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.73e-04 | 177 | 32 | 3 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.73e-04 | 177 | 32 | 3 | 7f9c2a45a994b32f15e5693f7cb873716a4eb568 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.73e-04 | 177 | 32 | 3 | 3ed383e5c0b15d9d5e75b98cf6d10609f48fc422 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.78e-04 | 178 | 32 | 3 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 178 | 32 | 3 | 9b932b677ae05ac6e12cd6ce97789f8c10e4790b | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Macrophage|lymph-node_spleen / Manually curated celltypes from each tissue | 2.82e-04 | 179 | 32 | 3 | b4430f633711cecf793e8e76e766a66ff1eff473 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.82e-04 | 179 | 32 | 3 | 747a32460b257fffca30527b56a74720eb9c12e4 | |
| ToppCell | Leuk-UTI-Lymphocyte-B-B_intermediate|Leuk-UTI / Disease, Lineage and Cell Type | 2.82e-04 | 179 | 32 | 3 | 01933f6fa94d7032ed403a6cae6985cafa820043 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-04 | 180 | 32 | 3 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 2.87e-04 | 180 | 32 | 3 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-04 | 180 | 32 | 3 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 180 | 32 | 3 | f9f8245cbcdea18c15e2976c85b72c6807309787 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-04 | 180 | 32 | 3 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.87e-04 | 180 | 32 | 3 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | droplet-Limb_Muscle-nan-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 180 | 32 | 3 | d3d0be136fff5d3e39ecf5a5dbefc1d0d0a6c814 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.91e-04 | 181 | 32 | 3 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Macrophage|bone_marrow / Manually curated celltypes from each tissue | 2.91e-04 | 181 | 32 | 3 | d2aa5b53162fb5c4cbbedbd2cb4b2b614e8c4afa | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.91e-04 | 181 | 32 | 3 | 1aebb62ed4439db444ee9d30688212b86ee3d9ef | |
| ToppCell | PCW_10-12-Neuronal-Neuronal_postreplicative-neuro_NA|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.91e-04 | 181 | 32 | 3 | 6aee2ddee4790250ef3b2ef0038bd9839925c995 | |
| ToppCell | PCW_10-12-Neuronal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.91e-04 | 181 | 32 | 3 | 381b553e2cae65ce6be100662a5f9f963353840c | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.91e-04 | 181 | 32 | 3 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 2.96e-04 | 182 | 32 | 3 | 84018a84e1aa52fa52ccfc26db9cd1fb6d535b31 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.96e-04 | 182 | 32 | 3 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.96e-04 | 182 | 32 | 3 | f7f9be9c7ef8da9864d6aefe20043b26e1bb8697 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.96e-04 | 182 | 32 | 3 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 183 | 32 | 3 | 5cfcd589a480e67654d3d94e71916f122150db10 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 183 | 32 | 3 | c3ea8d3b916ffcaca3156e0d77a952724554c4ab | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.01e-04 | 183 | 32 | 3 | f517215ff45dec914af52dfdbc4579c19654c3aa | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.01e-04 | 183 | 32 | 3 | 2beb5414958d38a5341870d55229f3b1707e76bf | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.01e-04 | 183 | 32 | 3 | 4cc0961a67de76b8d756cd9ffcaa98e3fe3c3a69 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 183 | 32 | 3 | 81003ddc24164959dd41bb12fcac72638789b8f2 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.01e-04 | 183 | 32 | 3 | e0854864d377e158a4793088d1cb6b3dbf2c805d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.06e-04 | 184 | 32 | 3 | e343dd7777a29048e3f12a939f7f782b8b7b4fea | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 185 | 32 | 3 | 3cd0686a14e734a0f243070ab939adcb4c454478 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 185 | 32 | 3 | 00258f458cbf6d36449db95528a6b5038d731d2d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 185 | 32 | 3 | a94694e226856bc5b168464f52d76004145717a5 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.11e-04 | 185 | 32 | 3 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-04 | 185 | 32 | 3 | f607b6ee579562e2f92103fa5c7053df0170a229 | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-04 | 185 | 32 | 3 | 317f2c854f00aa5957319b818c85eeed7d72ec7f | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.11e-04 | 185 | 32 | 3 | 7bb8fdfe04f85d25056380ec58222366de323a21 | |
| ToppCell | facs-Heart-LA-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 186 | 32 | 3 | 246503fd4e6ae24041c606b069eb5fb313e60f73 | |
| ToppCell | facs-Heart-LA-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 186 | 32 | 3 | ef93ac469eb4f63db036f14b442c1503b8c6de38 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.16e-04 | 186 | 32 | 3 | 3113c85d0ac5fc46532c19b1bb71f34b985e1276 | |
| ToppCell | PCW_07-8.5-Neuronal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.16e-04 | 186 | 32 | 3 | 7a4bb42f3f6a27b463e48eafc587d9ab3386f2fb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-04 | 186 | 32 | 3 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.16e-04 | 186 | 32 | 3 | d3509a579871ba6a8c4edd6137b28f271c9dbe70 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.16e-04 | 186 | 32 | 3 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.21e-04 | 187 | 32 | 3 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| Computational | Neighborhood of MLL | 1.04e-04 | 174 | 16 | 4 | GCM_MLL | |
| Drug | Deltaline [6836-11-9]; Up 200; 7.8uM; HL60; HT_HG-U133A | 7.87e-06 | 198 | 32 | 5 | 2171_UP | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 8.01e-06 | 118 | 32 | 4 | EFO_0010119 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 1.29e-05 | 42 | 32 | 3 | EFO_0022255 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 2.04e-05 | 312 | 32 | 5 | EFO_0004612, EFO_0010351 | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 2.38e-05 | 7 | 32 | 2 | EFO_0004614, EFO_0006925 | |
| Disease | low density lipoprotein particle size measurement | 3.43e-05 | 58 | 32 | 3 | EFO_0008593 | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 4.08e-05 | 9 | 32 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | dental caries, dentures | 6.04e-05 | 70 | 32 | 3 | EFO_0003819, EFO_0010078 | |
| Disease | dentures | 6.04e-05 | 70 | 32 | 3 | EFO_0010078 | |
| Disease | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage | 1.19e-04 | 15 | 32 | 2 | EFO_0022328 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 1.53e-04 | 17 | 32 | 2 | EFO_0022232 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 2.13e-04 | 274 | 32 | 4 | EFO_0004530, EFO_0004612 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | 2.25e-04 | 109 | 32 | 3 | EFO_0004639, EFO_0008317, EFO_0008596 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.31e-04 | 110 | 32 | 3 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 2.31e-04 | 110 | 32 | 3 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.31e-04 | 110 | 32 | 3 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 2.36e-04 | 21 | 32 | 2 | EFO_0022277 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 2.36e-04 | 21 | 32 | 2 | EFO_0022246 | |
| Disease | docosahexaenoic acid to total fatty acids percentage | 2.36e-04 | 21 | 32 | 2 | EFO_0022262 | |
| Disease | lipoprotein A measurement | 2.44e-04 | 112 | 32 | 3 | EFO_0006925 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 3.10e-04 | 24 | 32 | 2 | DOID:10595 (implicated_via_orthology) | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 3.12e-04 | 303 | 32 | 4 | EFO_0004612, EFO_0020945 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 3.62e-04 | 315 | 32 | 4 | EFO_0004574, EFO_0004612 | |
| Disease | very low density lipoprotein particle size measurement | 4.04e-04 | 133 | 32 | 3 | EFO_0008594 | |
| Disease | triglyceride measurement, phospholipid measurement | 5.30e-04 | 146 | 32 | 3 | EFO_0004530, EFO_0004639 | |
| Disease | photoreceptor cell layer thickness measurement | 5.51e-04 | 148 | 32 | 3 | EFO_0803370 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 5.73e-04 | 150 | 32 | 3 | EFO_0004611, EFO_0020947 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 6.07e-04 | 153 | 32 | 3 | EFO_0004611, EFO_0020946 | |
| Disease | low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 6.07e-04 | 153 | 32 | 3 | EFO_0004611, EFO_0020944 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 6.25e-04 | 34 | 32 | 2 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 6.25e-04 | 34 | 32 | 2 | EFO_0008317, EFO_0008596, EFO_0020947 | |
| Disease | breast carcinoma | 7.01e-04 | 1019 | 32 | 6 | EFO_0000305 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 7.69e-04 | 166 | 32 | 3 | EFO_0004530, EFO_0004611 | |
| Disease | degree of unsaturation measurement | 8.23e-04 | 39 | 32 | 2 | EFO_0022261 | |
| Disease | aspirin use measurement | 8.23e-04 | 39 | 32 | 2 | EFO_0007013 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 1.00e-03 | 43 | 32 | 2 | EFO_0022254 | |
| Disease | saturated fatty acids measurement | 1.10e-03 | 45 | 32 | 2 | EFO_0022304 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 1.10e-03 | 45 | 32 | 2 | EFO_0022236 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.14e-03 | 46 | 32 | 2 | EFO_0008317, EFO_0008596, EFO_0020943 | |
| Disease | Celiac Disease | 1.19e-03 | 47 | 32 | 2 | C0007570 | |
| Disease | fatty acid measurement | 1.22e-03 | 436 | 32 | 4 | EFO_0005110 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 1.26e-03 | 197 | 32 | 3 | EFO_0005680 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 1.30e-03 | 49 | 32 | 2 | EFO_0022256 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.32e-03 | 200 | 32 | 3 | EFO_0004611, EFO_0020945 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 1.35e-03 | 50 | 32 | 2 | EFO_0022334 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 1.35e-03 | 50 | 32 | 2 | EFO_0022303 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 1.35e-03 | 50 | 32 | 2 | EFO_0022247 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 1.41e-03 | 51 | 32 | 2 | EFO_0022302 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HRSSCERTRHSPSEM | 1901 | Q68DN1 | |
| EIPNMSDHTTVHWAR | 561 | Q9UKF5 | |
| RRRHHMSMWEPRSSH | 751 | Q15878 | |
| DGIPIMRWHHRTTVS | 191 | P22352 | |
| PWHTHLEMHCLVQTS | 116 | Q5JTZ5 | |
| PEWQMCHSIPVSHIR | 606 | O95294 | |
| WIRHHVTTMSERTFP | 286 | Q03001 | |
| CAVVRDNWHEHISMP | 816 | Q76MJ5 | |
| CVLHPAWAQNHRTMS | 126 | P25089 | |
| SHNWMHCRPRTIDTT | 466 | Q99542 | |
| TEVTRWVPDHMASHC | 1106 | Q9NYA4 | |
| WHQVAPMHSRRCYVS | 366 | Q6JEL2 | |
| GRTCQAWSSMTPHQH | 46 | P08519 | |
| RTCQAWSSMTPHSHS | 161 | P08519 | |
| TCQAWSSMTPHSHSR | 276 | P08519 | |
| CQAWSSMTPHSHSRT | 391 | P08519 | |
| GRTCQAWSSMTPHSH | 616 | P08519 | |
| RTCQAWSSMTPHSHS | 731 | P08519 | |
| TCQAWSSMTPHSHSR | 846 | P08519 | |
| CQAWSSMTPHSHSRT | 961 | P08519 | |
| RTCQSWSSMIPHWHQ | 1521 | P08519 | |
| TCQSWSSMTPHRHQR | 1636 | P08519 | |
| QHSCLSHSRWLRSPQ | 46 | Q7Z601 | |
| RWARVHSMSVRLTCH | 146 | Q1MX18 | |
| MRHSKRTHCPDWDSR | 1 | Q9HAZ1 | |
| TSVEHPRNLVMDHCW | 2781 | Q6ZTR5 | |
| RQTVMTSATWPHSVH | 421 | Q9NXZ2 | |
| TEMTRWLPDHLAAHC | 1111 | Q13615 | |
| QMHSVTLHPSTWLRN | 1026 | Q9P2F6 | |
| GRTCQAWSSMTPHQH | 46 | Q16609 | |
| QANRHWHSESPLMCV | 2246 | Q4LDE5 | |
| ETHRAPDLVQWTRHM | 31 | O75908 | |
| HTILSPWMRSSSEHC | 331 | Q9UM73 | |
| PWASSLQRHMLTHTD | 1256 | Q92766 | |
| CVHKWLTSMQDHSRP | 706 | Q8TEQ6 | |
| CPMESRHATYSWRHK | 566 | O75326 | |
| RHERWNCMITAAATT | 86 | Q9UBV4 | |
| QRLEESMHRWSPHCA | 101 | Q86XT2 | |
| CVTAMCFHPRRESHW | 221 | Q86XT9 | |
| SHSRRQPHVMSQWSR | 331 | P21754 | |
| LWNESHRCMETTPSL | 336 | Q6NUM6 | |
| HLRPTVHQTLMWRSD | 591 | Q9ULJ6 |